Pro-Dex (co) EBIT

The latest EBIT for PDEX is $12M as of March 2026. That compares with $12M in the prior-year period — down 7.0% year over year. That is below the Healthcare sector average of $22B. Investors often review this figure alongside Pro-Dex (co)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, PDEX's EBIT moved from $12M to $12M — a 7.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Pro-Dex (co)'s operating scale or balance-sheet position.

Against Healthcare companies, PDEX currently prints $12M for EBIT, while the sector average sits near $22B. That is roughly 99.9% below the sector mean. Large gaps often invite a closer look at Pro-Dex (co)'s growth, margins, and balance sheet.

A EBIT figure of $12M for PDEX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $22B. Explore the charts below for those layers of context.

After noting PDEX's EBIT ($12M), review year-over-year change from $12M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.